Judge blocks Massachusetts ban on painkiller

by Steve Leblanc

A federal judge has blocked Massachusetts from banning the powerful new painkiller Zohydro.

The judge issued a Tuesday after pharmaceutical company, Zogenix, argued in a lawsuit that the ban issued by Gov. Deval Patrick in March is unconstitutional. The judge said Massachusetts appears to have overstepped its authority in banning a federally approved medication.

The state argued that Zohydro will exacerbate a drug overdose problem in Massachusetts because Zohydro can be easily crushed, then snorted or injected to create an immediate and potentially lethal high.

The National Alliance for Model State Drug Laws says the Massachusetts ban is believed to be the first attempt by a state to block a federally approved drug.

The San Diego-based drugmaker hailed the Tuesday ruling. Massachusetts officials are reviewing it.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

States revolt against powerful new painkiller

Apr 04, 2014

State officials fighting a well-publicized battle against heroin and prescription drug abuse are revolting against a powerful new painkiller that law enforcement and public health officials fear could worsen ...

Sen. Joe Manchin seeks to block new painkiller

Mar 11, 2014

U.S. Sen. Joe Manchin is calling on the government's top health official to overturn the approval of a powerful painkiller, arguing that the pill Zohydro could add to the national epidemic of prescription drug abuse.

US panel opposes pure hydrocodone painkiller

Dec 09, 2012

(AP)—U.S. government health experts overwhelmingly voted against a stronger version of hydrocodone on Friday, questioning the need for a new form of one of most widely abused prescription painkillers.

Recommended for you

Expression of privilege in vaccine refusal

7 hours ago

Not all students returning to school this month will be up to date on their vaccinations. A new study conducted by Jennifer Reich, a researcher at the University of Colorado Denver, shows that the reasons why children may ...

Using computers to design drugs

Aug 22, 2014

Designing a new medicine is an expensive and time consuming business. Typically it takes around $2 billion and ten years for a new drug to move from its initial design in the lab, to the clinic. All the ...

Lilly psoriasis drug fares well in late-stage test

Aug 22, 2014

Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

User comments